Clinical Trials · NCT05171751
Efficacy and Safety Evaluation of Octreotide in the Treatment of Congenital Hyperinsulinemia
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Beijing Children's Hospital
- Enrollment
- 50
- Start date
- Nov 2021
- Locations
- 1 site, China
- Primary endpoint
- blood glucose